|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||
| Condition | Onset Date / Period | Status |
|---|---|---|
| Metabolic syndrome X | 12-Sep-2011 | active |
| Essential hypertension | 12-Jun-1995 | active |
| Obstructive sleep apnea syndrome | 11-Apr-1994 | active |
| Sleep disorder | 23-Mar-1994 | active |
| Anemia | 08-Jun-1992 | active |
| Viral sinusitis | 05-Dec-2024 - 25-Dec-2024 | inactive |
| Viral sinusitis | 16-May-2024 - 01-Jun-2024 | inactive |
| Viral sinusitis | 15-Aug-2019 - 05-Sep-2019 | inactive |
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2024-11-25 | - | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2024-11-25 | - | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2024-11-25 | - | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 25-Nov-2024 |
| SARS-CoV-2 mRNA vaccine | 22-Feb-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 05-Oct-2015 |
| Live attenuated Human alphaherpesvirus 3 only vaccine product | 05-Oct-2015 |
| No known procedures |
| No known allergies or intolerances |
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 12-Jun-1995 | Essential hypertension (disorder) |
|
||
| Care plan | 11-Apr-1994 | Obstructive sleep apnea syndrome (disorder) |
|
||
| Diabetes self management plan | 05-Jun-1989 | Prediabetes (finding) |
|
| Vital Signs | 2024-11-25 | 2023-11-20 |
|---|---|---|
| Body Height | 172.5 cm | 172.5 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 {score} | 3 {score} |
| Body Weight | 81.4 kg | 81.4 kg |
| Body mass index (BMI) [Ratio] | 27.4 kg/m2 | 27.4 kg/m2 |
| Heart rate | 70 /min | 83 /min |
| Respiratory rate | 14 /min | 15 /min |
| Blood pressure panel with all children optional | 80 mm[Hg] | 83 mm[Hg] |
| Recent Lab Observations | 25-NOV-2024 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 98.2 | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 12.4 | 7 - 18 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 9.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 137.9 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 5.2 H | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 103.0 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 24.1 | 22 - 29 | mmol/L |
| Device | Date (since) |
|---|---|
| Home continuous positive airway pressure unit (physical object) | 14-Nov-2022 |
| Respiratory humidifier (physical object) | 14-Nov-2022 |
| Blood glucose meter (physical object) | 05-Jun-1989 |